Protein A immunoadsorption combination with immunosuppressive therapy improves neuropsychiatric systemic lupus erythematosus: A case report-Reference-Cited by-同舟云学术

Protein A immunoadsorption combination with immunosuppressive therapy improves neuropsychiatric systemic lupus erythematosus: A case report

Published:2020-07-16 Issue:11 Volume:8 Page:2158-2162
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Wen Feng¹,Wu Xiaoling²³,Liao Ruyi¹,Feng Zhonglin¹,Li Zhilian¹,Fu Xia¹,Fu Lei¹,Li Sijia¹,Li Zhuo¹,Li Sheng¹,Wang Wenjian¹,Huang Biao²³,He Chaosheng¹,Wei Shi¹,Liang Xinling¹²,Liu Shuangxin¹²^ORCID

Affiliation:

1. Department of Nephrology Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

2. Medical School South China University of Technology Guangzhou China

3. Department of Radiology Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.3140

Reference17 articles.

1. Systemic Lupus Erythematosus

2. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus

3. IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study

4. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus

5. Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Clinical Nursing Pathway in the Peri-Treatment Period of Immunoadsorption Therapy for Rheumatic Immune Diseases;Yangtze Medicine;2023

2. Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge;Current Pharmaceutical Design;2022-03